Please login to the form below

Q2 results

This page shows the latest Q2 results news and features for those working in and with pharma, biotech and healthcare.

alone. In Q2, Pfizer’s revenues were up 86% operationally to $19bn – excluding sales of the BNT162b2 vaccine, revenues were still up 10% to $11bn.

Investors respond positively to “strong” Eli Lilly results

Lilly bets on Alzheimer’s drug after missing profits expectations
Sanofi raises profit forecast following positive Q2 results

Sales for Q2 were driven by the company’s eczema drug and its vaccines portfolio. ... Sanofi also stressed several important R&D milestones and regulatory achievements in Q2:.
Gilead delivers a “solid quarter” with revenues up $1.52bn

Recent results in virology for lenacapavir, which reinforces its potential as a long-acting therapy for people living with HIV. ... Positive interim results from Hepcludex studies in HDV, which moves the drug closer to a US filing.
Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’

Merck &Co announced that sales grew by 19% in the second quarter (Q2) as key products begin to recover from the impact of the COVID-19 pandemic. ... Elsewhere in its Q2 results, Merck saw sales growth for its blockbuster immunotherapy Keytruda, which
GSK beats expectations thanks to strong vaccine sales in Q2

In the first financial results presentation since the company came under fire from activist hedge fund Elliott Management, GSK posted second-quarter revenue of £8.1bn, above average analyst estimates of ... EMA). In Q2, GSK announced $16m in sales for

More from news
Approximately 20 fully matching, plus 26 partially matching documents found.

Interview: Joseph Jimenez, Novartis

Our broad, yet focused, portfolio delivered strong results in Q2, with sales growing 19 per cent. ... Consumer health grew five per cent in Q2, largely due to products like Theraflu and Voltaren.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Senior Consultant, Pricing & Market Access Consultancy, circ...: circa £100K package

Digital Project Director, Healthcare Marketing Agency patient fo...: Highly competitive salary

Senior Medical Writer/ Copywriter, Flexible Location, Flexible D...: Salary TBC

Group Account Director, Patient focussed account, Healthcare com...: circa £90K

Digital Engagement Strategist, Healthcare Brand Communications, ...: £75-90K

Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...: Highly competitive salary

Project Director, Healthcare Marketing Agency patient focus Lond...: Highly competitive salary

Add my company

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Ask the writers: Transitioning from academia to medical writing: Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset: By James Aird...
Guide: How to embrace behavioural science principles in healthcare MR...

Email:
Password: